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ABSTRACT
DNA mismatch repair (MMR) sensitizes human and
Escherichia coli dam cells to the cytotoxic action of
N-methyl-N 0-nitro-N-nitrosoguanidine (MNNG) while
abrogation of such repair results in drug resistance.
In DNA methylated by MNNG, MMR action is the result
of MutS recognition of O6-methylguanine base pairs.
MutS and Ada methyltransferase compete for the
MNNG-induced O6-methylguanine residues, and
MMR-induced cytotoxicity is abrogated when Ada is
present at higher concentrations than normal. To test
the hypothesis that MMR sensitization is due to
decreased recombinational repair, we used a RecA-
mediated strand exchange assay between homo-
logous phiX174 substrate molecules, one of which
was methylated with MNNG. MutS inhibited strand
transfer on such substrates in a concentration-
dependent manner and its inhibitory effect was
enhanced by MutL. There was no effect of these pro-
teins on RecA activity with unmethylated substrates.
We quantified the number of O6-methylguanine resi-
dues in methylated DNA by HPLC-MS/MS and 5–10 of
these residues in phiX174 DNA (5386 bp) were suffi-
cient to block the RecA reaction in the presence of
MutS and MutL. These results are consistent with
a model in which methylated DNA is perceived by
the cell as homeologous and prevented from recom-
bining with homologous DNA by the MMR system.
INTRODUCTION
Methylating agents are found in the environment and are also
used in cancer chemotherapy (1–3). These agents and labor-
atory versions, such as N-methyl-N0-nitro-N-nitrosoguanidine
(MNNG), can react with DNA to create a variety lesions acted
upon by different DNA repair pathways; such lesions include
N7-methylguanine (7-meG) and O6-methylguanine (O6-meG),
the latter being the subject of this investigation. In Escherichia
coli, two methyltransferases can use O6-meG as a substrate:
the constitutively produced Ogt protein and the inducible Ada
protein (4). In order to demethylate an O6-meG, the Ada pro-
tein binds directly to the base, flips it out of the helix and into
its substrate binding pocket, transferring the methyl group
from the base to an internally located cysteine residue (5).
The Ada protein also has a regulatory function to induce itself
and other genes of the ada regulon, including alkA, alkB and
aidB (1,3).
O6-meG paired with cytosine or thymine is also a substrate
for the MutS protein of the E.coli DNA mismatch repair
(MMR) system (6,7). The Dam-directed MMR system of
E.coli acts to preserve the fidelity of the genome by removing
base mismatches that arise as a result of replication (mutation
avoidance) (8–10). During replication, the parental DNA
strand is methylated at all adenines in the sequence GATC
by the product of the dam gene. The newly synthesized strand
is not yet methylated, due to a lag between replication and
methylation by Dam, which leaves a hemi-methylated DNA
state behind the replication fork. The MMR system exploits
the hemi-methylated state of the DNA by allowing it to
distinguish the new strand from the old strand for repair.
When mismatches arise in the hemi-methylated region of
DNA, they are first bound by the MutS protein. MutS then
recruits MutL and MutH to form a ternary complex, which
activates the latent endonuclease activity of MutH. Incision by
MutH occurs at a nearby GATC sequence on the unmethylated
strand, followed by exonucleolytic digestion to remove
the mismatch. The gap produced by exonuclease action is
re-synthesized by the replicative polymerase, DNA poly-
merase III, which restores the correct nucleotide sequence
and the remaining nick is sealed by DNA ligase. Subsequently,
the repaired strand will be methylated by the Dam methyl-
transferase at GATC sequences, and this methylation step
prevents further action by the MMR system.
In E.coli mutant in the dam locus, both strands of DNA are
unmethylated and the directionality of MMR is lost, allowing
MutH to incise the daughter or parental DNA strands during
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repair (11). Thus, MutH endonuclease action can occur in
both replicating and non-replicating DNA, anywhere in the
chromosome, unlike in wild-type cells where MMR is tightly
regulated to the region trailing the replication fork. MutH
action can occur either at the same GATC on opposite strands
(12) or by replication fork collapse (11,13). These actions
result in the formation of double-strand breaks (DSBs),
which require recombination to restore genomic integrity,
as mutations in genes encoding recombination proteins in
combination with dam results in a lethal phenotype (11).
MMR also plays an important role in preventing recomb-
ination between similar but non-identical (homeologous)
DNA sequences, a function termed anti-recombination (14).
Salmonella enterica serovar Typhimurium and E.coli share an
83% sequence identity, and genetic crosses between them are
sterile unless a mutation in the mutS or mutL genes is present
in the recipient (14). Recombination is increased by at least
1000-fold in recipients where MMR is inactivated and
chimeras containing DNA from both species are formed.
Biochemical experiments using homeologous DNA from
the closely related M13 and fd phages (3% sequence diver-
gence) showed that the addition of MutS and MutL protein
block the progression of the RecA-mediated strand exchange
reaction in vitro (15). There was no effect of MutS and MutL
when homologous M13–M13 substrates were used. The
genetic and biochemical results imply that MMR impedes
or actively reverses recombination intermediates with the
former having experimental support (9,16).
E.coli dam mutants are more susceptible to the cytotoxic
action of MNNG and other chemical agents than wild-type
(17–19). Mutations inactivating MMR (mutS, mutL) in a dam
background confer a level of resistance to MNNG similar to
wild-type (17,19). This indicates that MMR can act on chem-
ically modified substrates through MutS binding specifically
to O6-meG base pairs (6,7). MMR action at these base pairs
may lead to the formation of nicks or gaps, which are con-
verted to DSBs requiring recombination to repair them. We
hypothesize that inhibition of recombinational repair by MMR
would ensue because the homologous methylated DNA is
perceived as homeologous DNA (20). Persistent unrepaired
DSBs would eventually produce lethality. We have advanced
a similar hypothesis to explain MMR sensitization of dam cells
exposed to cisplatin in which dose- and MMR-dependent
DSBs accumulate (13). MutS prevents RecA-mediated
strand transfer with substrate DNAs containing platinated
intrastrand crosslinks (21). In this work, we demonstrate a
similar result with O6-meG base pairs.
MATERIALS AND METHODS
Strains, media and chemicals
The E.coli K-12 strains used in this study are described
in Table 1. Plasmid pBAR, a pEMBL derivative that
contains the ada gene under control of an isopropyl-b-D-
thiogalactopyranoside (IPTG) inducible promoter (22), was
a gift from Dr Bruce Demple (Harvard School of Public
Health, Boston). L medium contains 20 g tryptone (Difco),
10 g yeast extract (Difco), 0.5 g NaCl, 4 ml of 1 M NaOH per
liter and solidified when required with 16 g of agar. Minimal
medium was prepared as described by Davis and Mingioli
(23). MNNG (Sigma–Aldrich) was prepared by dissolving
1 mg of MNNG in 100 ml of dimethyl sulfoxide and adding
900 ml of sterile water and aliquots were stored frozen at
20C. Guanine, 7-methylguanine and O6-meG were
obtained from Sigma–Aldrich.
Proteins and DNA
RecA protein was purified as described previously (21). MutS
and MutL proteins were a gift from F. Lopez de Saro and
M. O’Donnell (The Rockefeller University). Single-stranded
binding protein (Ssb) was obtained from USBiological.
PhiX174 RFI (covalently closed circular) and virion
(single-stranded) forms were purchased from New England
Biolabs. The PhiX174 RFI DNA was digested with XhoI
restriction endonuclease to produce linear double-stranded
DNA for strand exchange.
Cell survival
Cells were grown in 10 ml L medium to an OD600 of
0.35–0.45. The logarithmic phase cells were exposed to
various concentrations of MNNG for 10 or 30 min as indic-
ated, at 37C. Serial dilutions of MNNG-exposed cells were
plated on L media and incubated overnight. Colony forming
units were counted and survival calculated.
Methylation and survival of phiX174 DNA
PhiX174 RFI and linearized RFI DNA molecules were reacted
with various amounts of MNNG using a protocol adapted from
Sussmuth et al. (24). The DNA (50 mg) was added to 0.1 M
citric acid phosphate buffer, pH 6, containing 0.5 mM cysteine
and varying amounts of MNNG. The solution was rocked
gently at 37C for 4 h, after which the DNA was ethanol
precipitated four times to remove residual MNNG. For the
phage survival, aliquots of methylated or unmodified RFI
were mixed with strains MV1161 (wild type) and MV3855
(alk tag), mixed with top agar and poured onto Luria–Bertani
Table 1. E.coli strains
Strain Genotype Source/reference
AB1157 thr-1 ara-14 leuB6 D (gpt-proA)62
lacY1 tsx-33 supE44 galK2
hisG4 rfbD1 mgl-51 rpsL31
kdgK51 xyl-5 mtl-1 argE3 thi-1
E. A. Adelberg
GM2927 As AB1157 but dam-13::Tn9 Lab stock
GM3819 As AB1157 but Ddam-16::Kan Lab stock
GM7688 As GM3819 but DmutL460::Cam Lab stock
GM7704 As GM2927 but DmutS465::Tet Lab stock
GM7797 As GM3819 but DmutS465::Tet Lab stock
GM8415 As AB1157 but Dada::Kana Lab stock
GM8417 As KM55 but Ddam-16::Kan Lab stock
GM8427 As GM2927 but Dada::Kan Lab stock
GM8440 As GM7704 but Dada::Kan Lab stock
KM55 As AB1157 but DmutH461::Cam K. C. Murphy (36)
KT233 Dada::Kan Dtag::Cam B. Sedgwick (37)
MV1161 As AB1157 but rfa-550 M. Volkert
MV3855 As MV1161 but alkA1 tagA1
zhb::Tn5 uvrA6
M. Volkert
Further information about strains and markers can be found at http://users.
umassmed.edu/martin.marinus/dstrains.html.
aAlthough designated as Dada::Kan, this deletion also removes the alkB gene.
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plates. The plates were incubated overnight at 37C and
plaques scored.
HPLC-MS/MS
Calculation of the number of methylated purine bases in
each of the DNA substrates was determined by reverse
phase high-performance liquid chromatography (HPLC) with
online positive ion electrospray multiple reaction monitoring
MS/MS (HPLC-ESI-MRM-MS/MS). HPLC was performed
using a Rheos microgradient pumping system (Leap Techno-
logies, Inc.) with a 150 · 1 mm ID BetaBasic-18 (3 mm par-
ticle size, 150 s pore, Keystone Scientific, Inc.) in the isocratic
mode with 2% acetonitrile, 0.1% formic acid as the mobile
phase at 50 ml/min. The column outlet was directly connected
to the Z-Spray ion source on a Quattro-II triple quadrupole
mass spectrometer (Waters). Optimal MS conditions for each
analyte were determined by adjustment of conditions during
infusion of solutions of each analyte in mobile phase with
the capillary at 2.4 kV and collision cell argon pressure at
1 mBar. Guanine was measured by MRM of the transition
from the m/z 136 (MH+) to m/z 92 with the cone at 30 V,
collision energy at 30 V and a dwell time of 0.05 s. 7-meG was
measured by MRM of the transition from the m/z 166 (MH+)
to m/z 124 with the cone at 35 V, collision energy at 23 V and
a dwell time of 0.5 s. O6-meG was measured by MRM of the
transition from the m/z 166 (MH+) to m/z 134 with the cone at
35 V, collision energy at 24 V and a dwell time of 5 s. Amounts
of each analyte in the samples were calculated by comparison
of sample peak areas with those measured from injection of
external standards. The methylated DNA was subject to formic
acid hydrolysis using 65% formic acid for 30 min at 130C.
Strand exchange assay
Reaction mixtures contained 25 mM Tris-acetate, pH 7.5,
10 mM MgOAc, 5% glycerol, 1 mM DTT, 8 mM phospho-
creatine, 10 U/ml creatine kinase, 1 nM single-stranded
circular DNA and 6.7 mM RecA. Reaction mixtures were
pre-incubated at 37C for 10 min, linear duplex DNA substrate
was added to a concentration of 0.8 nM and incubated
an additional 10 min. Strand exchange was initiated by the
addition of a premixed solution containing 2 mM Ssb and
3 mM ATP. MutS and/or MutL were added 1 min prior to
initiation of the reaction. Samples were taken at indicated
times and strand transfer was terminated by the addition of
2 ml of buffer containing 5% SDS, 20% glycerol, 60 mM
EDTA and Proteinase K to a concentration of 1 mg/ml.
After incubation at 42C for 30 min, samples were analyzed
by electrophoresis in a 0.8% agarose gel with 40 mM
Tris–acetate, 2 mM EDTA. Gels were processed by staining
in Vistra Green (Amersham) fluorescent stain (1:10 000) for
60 min and then analyzed by Image Reader 1 Laser/1 Image
at 473 nm on a Fuji FLA-5000 phosphorImager. The gels were
quantified using Multi-gauge V.2.3 software.
RESULTS
Survival of dam strains exposed to MNNG
We have used deletion mutations in the dam, mutS, mutL and
mutH genes to measure survival of strains containing them to
MNNG exposure. The data in Figure 1 show that the dam
mutant is more sensitive to MNNG than wild type. The double
mutants, dam mutS, dam mutL and dam mutH, have a level of
resistance equivalent to wild type. These results confirm pre-
vious data where inactivation of MMR by presumed base
substitution mutations mutS and mutL in a dam background
results in drug resistance. In contrast to a previous study (19),
we find that the dam mutH strain is as resistant to MNNG
as wild type.
The effect of Ada protein on cell survival
We also examined the role of the Ada protein on dam cell
survival by using strains in which it was overproduced from a
multicopy plasmid or was absent due to an ada gene deletion.
The dam ada double mutant is more sensitive to MNNG than
dam alone (Figure 2A), but overexpression of the Ada protein
in both these strains results in a wild-type level of resistance
(Figure 2B), indicating that Ada methyltransferase can
prevent MMR-induced cytotoxicity. The survival of Ada
overproducing wild-type and dam mutS strains was not signi-
ficantly different from the Ada-oveproducing strains shown
in Figure 2B (data not shown). We conclude that these results
are consistent with competition between Ada and MutS for
substrate, which we assume is O6-meG base pairs.
The increased sensitivity of the dam ada double mutant
compared with the dam strain alone suggests an ada-
dependent mechanism of sensitization distinct from that
caused by MMR. Further evidence for this idea is that the
survival of the dam ada mutS triple mutant is less than that
for the dam mutS double (Figure 2A). As expected, the ada
derivative of the wild type also shows increased sensitivity
(Figure 2A) under the same experimental conditions.
Methylation of DNA by MNNG and determination of the
number of lesions by HPLC-ESI-MRM-MS
The double-stranded linear form of phiX174 DNA (5386 bp)
was reacted with 0, 150, 300 and 600 mM MNNG. After formic
acid hydrolysis, the levels of guanine, 7-meG and O6-meG
for each substrate were measured by HPLC-ESI-MRM-MS.
Figure 1. Cell survival after exposure to MNNG. Cells in the logarithmic phase
of growth were exposed to MNNG for 10 min (to prevent substantial induction
of Ada methyltransferase), diluted and portions spread on L agar to determine
survival. Filled circles, wild-type (AB1157); upside down triangles, Ddam
DmutS (GM7797); right side up triangles, Ddam DmutL (GM7688); crosses,
Ddam DmutH (GM8417); filled squares, Ddam (GM3819).
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The tracings in the top three panels of Figure 3 show the
retention times of the standards and the lower three panels
from MNNG methylated phiX174 DNA. Extrapolating
from linear calibration curves, there were 0, 5–10, 10–20
and 20–40 O6-meG residues in DNA treated with 0, 150,
300 and 600 mM MNNG, respectively, in multiple trials.
Survival of methylated phiX174 DNA
We methylated phiX174 RFI (covalently closed) DNA to
examine the relationship between transfection efficiency of
RFI DNA methylated with 0, 150, 300 and 600 mM MNNG
in wild-type and alkA tag bacteria. The alk tag strain was
chosen because it is a direct measure of survival of methylated
phage DNA since potentially lethal types of base methylation,
such as 3-methyladenine, are not removed by the AlkA and
TagA glycosylases. The data in Figure 4 show that at con-
centrations above 150 mM, there was a lower survival of the
treated phage DNA in the alkA tag strain, indicating the pres-
ence of inhibitory methylated lesions.
RecA strand exchange with unmodified and methylated
substrates
The strand exchange reaction is schematically represented in
the top panel of Figure 5. An example of a typical assay result
showing the separation of the various substrates and products
using linear duplex (DS) methylated with 600 mM MNNG is
shown in the bottom panel of Figure 5. We used DS methyl-
ated DNA because the types and abundance of methylated
bases differ from that in single-stranded (SS) DNA and DS
DNA is the probable target in vivo. The results of the RecA
assay with unmethylated and methylated DNA and various
concentrations of MutS and MutL are shown in Figure 6.
The first four lanes in Figure 5 show the reaction with methyl-
ated DNA but the identical result was obtained with unmethyl-
ated DNA (data not shown), indicating that methylated bases
do not interfere with RecA action at any concentration of
MNNG used (Figure 6). In the absence of MutS, the reaction
is complete within 45 min (Figures 5 and 6) by measuring the
appearance of nicked circle (NC) product. Over time, there is
also an increase in slowly migrating intermediate (I) struc-
tures, the step which precedes the formation of the NC product.
Inclusion of MutS in the reaction with unmodified substrates
has no significant effect on the rate or yield of the reaction up
to concentrations of 250 nM (data not shown). At higher
concentrations, MutS begins to bind nonspecifically to
DNA, causing a slight inhibition of the reaction.
The addition of MutS to the RecA strand
exchange reaction
As described above, no change in rate or yield of product
is observed upon the addition of MutS to a strand transfer
reaction between unmethylated substrates. In contrast, inhibi-
tion of strand transfer occurs when MutS is added to a
reaction where the linear duplex substrate contains methylated
bases (Figure 5, 25 mM MutS). As shown in Figure 6, addition
of 25, 125 and 250 mM MutS results in a concentration-
dependent inhibition of strand exchange, when the linear
duplex substrate is modified by 150, 300 or 600 mM
MNNG corresponding to between 5–10, 10–20 and 20–40
O6-meG residues, respectively. At higher concentrations of
MNNG, the binding of MutS to the substrate is saturated,
as the percent NC formation is equal to that of the 600 mM
modified substrate (data not shown). At modifying concentra-
tions of MNNG below 150 mM, the binding of MutS has
no effect on product formation and is analogous to that of
the unmodified substrate as measured by product formation
(data not shown). Note that phiX174 RFI DNA treated with
150 mM MNNG shows no reduction in plaque formation
in transfection assays (Figure 4) but a reduction was seen at
300 and 600 mM MNNG-treated DNA.
Addition of MutL to the reaction
Previous studies with homeologous substrates (M13 and fd
DNA) have shown that MutL stimulates MutS binding to
mismatches during strand exchange when MutS is at sub-
optimal concentrations (15). The last four lanes in Figure 5
show the inhibitory effect of 50 mM MutL addition to a strand
A
B
Figure 2. Effect of Ada protein on cell survival after exposure to MNNG.
(A) Cells in the logarithmic phase of growth were exposed to MNNG for
30 min, diluted and portions spread on L agar to determine survival. Filled
circles, wild-type (AB1157); open circles, Dada (GM8415); upside down
triangles, Ddam DmutS (GM7797); filled squares, Ddam (GM3819); right
side up triangles, dam ada (GM8427); open squares, Ddam DmutS Dada
(GM8440). (B) Cells in the logarithmic phase of growth were exposed to
MNNG for 30 min, diluted and portions spread on L agar to determine survival.
Filled right side up triangles, dam ada (GM8427); filled squares, Ddam
(GM3819); open right side up triangles, dam ada (GM8427)/pBAR; filled
squares, Ddam (GM3819)/pBAR. The survival curves for AB1157/pBAR
and Ddam DmutS (GM7797)/pBAR were not significantly different from
the pBAR-containing strains shown. No IPTG was added to the cultures as
uninduced levels of Ada protein were sufficiently high.
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exchange reaction in the presence of a lower concentration
(25 mM) of MutS. Inclusion of 50 or 100 mM MutL in the
reactions in the presence of MutS with methylated substrates
severely reduces product formation by RecA (Figure 6). In the
absence of MutS, inclusion of up to 200 mM MutL has no
effect on the rate of product formation or yield of the reaction
with modified or unmodified substrates (data not shown).
DISCUSSION
The cytotoxic effects of both cisplatin and MNNG are
enhanced by MMR in dam bacteria (17–19). With cisplatin,
we have shown that it promotes dose- and MMR-dependent
DSB formation in dam cells (13). Genetic studies indicate
that recombination is required for the repair of such breaks
(25,26) and the initiation of recombination by RecA-mediated
strand transfer is inhibited by MutS if one of the recombining
partners contains platinated diguanosyl intrastrand cross-
links (21). MMR anti-recombination with platinated DNA
occurs because such DNA is recognized as homeologous
(20) in the same manner as that formed between E.coli
and Salmonella typhimurium, which are 17% divergent in
sequence (14). MMR-mediated inhibition of DSB repair
should lead to lethality since even a single unrepaired DSB
is expected to be lethal.
The results reported in this study begin to form a unified
hypothesis explaining why cisplatin and MNNG, compounds
that produce damage acted upon by different repair systems,
cause a similar sensitization by MMR in dam cells. MutS
prevents RecA strand transfer when one of the substrates
is either methylated or platinated. Since cisplatin has been
shown to induce DSB formation in dam cells (13), we predict
that MNNG will do so as well and experiments to test this
Figure 3. Detection of methylated guanines by HPLC-MS/MS. The top three panels are traces of a mixture of the indicated standard compounds while the bottom
three panels are traces from formic acid hydrolyzed MNNG treated (300 mM) phiX174 RFI DNA.
Figure 4. Phage phiX174 DNA survival after MNNG exposure. PhiX174 RFI
DNA was incubated with the indicated concentrations of MNNG as described
in Materials and Methods and used to transfect strains MV1161 (wild type)
and MV3855 (alkA tagA) and survival determined by plaque formation.
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prediction are in progress. If, indeed, this is the case, then
inhibition of DSB repair by anti-recombination underlies
MMR sensitization.
The data reported here and for cisplatin (21) begin to answer
how much modification in E.coli homologous DNA is required
before it is converted to homeologous DNA. Currently, it is
known that 192 mismatches, or 3% divergence, between M13
and fd (6407 nt) are sufficient for recognition as homeologous
DNA (15). The data in Figure 6 show that 5–10 O6-meG
residues in the 5386 bp phiX174 molecule (1–2 modified
bases per 1000 bp) are sufficient to provoke MutS and
MutL inhibition of strand exchange. With cisplatin, 4–8 plat-
inated intrastrand crosslinks in phiX174 are sufficient for a
substantial MutS inhibitory effect although, unlike the case
with O6-meG mismatches (Figure 6), intrastrand crosslinks
reduce the ability of RecA to perform strand transfer. With
this caveat in mind, the number of lesions required to effect
MutS inhibition of strand transfer is about the same (1–2 per
1000 bp).
The strand transfer experiments show that MutS must recog-
nize O6-meG paired with cytosine confirming the binding to
synthetic oligonucleotides containing such a base pair (6,7).
MutS affinity for O6-meG mismatches was at least 2-fold
lower than for G/T base pairs. We wish to emphasize that
even though MutS has a lower affinity for DNA containing
O6-meG/C mismatches, it is sufficient to produce a striking
reduction in strand transfer when a low number of such
mismatches are present. This argument also holds for platin-
ated DNA where platinated GG/CC crosslinks must be the
adducts recognized by MutS and which have lower affinity
for MutS than GG/CT crosslinks (7).
The E.coli dam mutant was shown to be more sensitive
than wild type to MNNG, but not dimethylsulfate, suggesting
that O6-meG was the lesion recognized by MMR (17).
Subsequently, it was shown that MutS was able to bind spe-
cifically to O6-meG base pairs in vitro (6,7). Overexpression
of Ada methyltransferase abrogates MMR sensitization of
dam mutants (Figure 2B) and in its absence, the sensitiza-
tion is enhanced (Figure 2A). A simple explanation for these
results is that the two proteins compete for the same substrate.
Given that Ada methyltransferase acts on O6-meG residues
(among others) and that MutS can also bind to O6-meG base
pairs, it is reasonable to assume that this is the modified base
in question and which is recognized in vivo.
Mammalian cells are sensitive to the cytotoxic action of
MNNG and cisplatin but MMR-deficient cell lines derived
from them are resistant to the action of these agents
(27–29), although this association for cisplatin has recently
been questioned (30,31). The MutS protein from human cells
specifically recognizes the platinated GG intrastrand crosslink
Figure 5. RecA-catalyzed strand transfer. The top of the figure shows a
schematic of the reaction. Single-strand (SS) circular DNA reacts with linear
duplex (DS) to form intermediate (I) structures, which are converted to nicked-
circle (NC) products. The fluorograph shows the results from the RecA strand
transfer assays with unmodified SS DNA and methylated DS DNA (600 mM
MNNG treatment) without MutS (left four lanes), with MutS (middle four
lanes) and with MutS and MutL (right four lanes). The numbers above the
lanes indicate the time of the reaction.
Figure 6. Kinetics of MutS inhibition of RecA-mediated strand exchange. The graphs show the effect on RecA strand transfer of varying concentrations of MutS with
or without MutL on unmodified or methylated DNA. DNA was exposed to 150, 300 and 600mM MNNG in A, B and C, respectively. Filled circles, unmodified DNA;
right side up triangles, methylated DNA; open squares, 25 mM MutS; filled squares, 100 mM MutS; upside down triangles, 250 mM MutS; crosses, 25 mM MutS plus
50 mM MutL; open circles, 100 mM MutS plus 100 mM MutL.
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and O6-meG-cytosine and thymine base pairs (32). The sens-
itization by MMR to cisplatin or MNNG has been proposed
to occur by several models, including futile repair cycles by
MMR at lesions followed by DSB formation and subsequent
signaling for cell cycle arrest and apoptosis (33). An altern-
ative model posits a direct link between lesion recognition by
MutS and a signal transduction cascade leading to cell death
(34,35). Insofar as the work reported here with E.coli can
be extrapolated to human cells, our results would favor the
DSB model.
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